Latest filings (excl ownership)
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
EFFECT
Notice of effectiveness
28 Jun 21
15-12B
Securities registration termination
22 Jun 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 21
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
POS AM
Prospectus update (post-effective amendment)
22 Jun 21
8-K
Completion of Acquisition or Disposition of Assets
15 Jun 21
8-K
Submission of Matters to a Vote of Security Holders
19 May 21
425
Business combination disclosure
18 May 21
10-Q
2021 Q1
Quarterly report
17 May 21
8-K
ReShape Lifesciencs Announces First Quarter 2021 Financial and Operational Results
17 May 21
DEFM14A
Proxy related to merger
13 Apr 21
10-K
2020 FY
Annual report
11 Mar 21
8-K
ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results
10 Mar 21
425
Business combination disclosure
20 Jan 21
8-K
Entry into a Material Definitive Agreement
20 Jan 21
425
Business combination disclosure
20 Jan 21
425
Business combination disclosure
20 Jan 21
Latest ownership filings
4
Steven Boyd
22 Jun 21
SC 13D/A
ARMISTICE CAPITAL, LLC
22 Jun 21
4
THOMAS STANKOVICH
17 Jun 21
4
Steven Boyd
4 Dec 20
4
Steven Boyd
17 Nov 20
4
Steven Boyd
12 Nov 20
4
Steven Boyd
4 Nov 20
4
Steven Boyd
25 Sep 20
4
Steven Boyd
22 Sep 20
4
THOMAS STANKOVICH
17 Sep 20
4
Steven Boyd
16 Sep 20
SC 13D/A
ARMISTICE CAPITAL, LLC
16 Sep 20
4
Steven Boyd
20 Aug 20
SC 13D/A
ARMISTICE CAPITAL, LLC
20 Aug 20
4
THOMAS STANKOVICH
20 Aug 20
4
Steven Boyd
21 Jul 20
4
Steven Boyd
15 Apr 20
SC 13D/A
ARMISTICE CAPITAL, LLC
1 Apr 20
4
Steven Boyd
27 Mar 20
SC 13G/A
ReShape Lifesciences Inc.
10 Feb 20
4
Steven Boyd
31 Jan 20
SC 13G/A
ReShape Lifesciences Inc.
21 Jan 20
4
Steven Boyd
23 Dec 19
4
Steven Boyd
18 Dec 19
4
Steven Boyd
11 Dec 19
4
Steven Boyd
6 Dec 19
4
Steven Boyd
27 Nov 19
4
Steven Boyd
22 Nov 19
4
Steven Boyd
18 Nov 19
SC 13D/A
ReShape Lifesciences Inc.
18 Nov 19
4
Steven Boyd
13 Nov 19
3
THOMAS STANKOVICH
8 Nov 19
SC 13G/A
ReShape Lifesciences Inc.
1 Oct 19
SC 13D/A
ReShape Lifesciences Inc.
30 Sep 19
4
Steven Boyd
25 Sep 19
4
Steven Boyd
19 Sep 19
4
Steven Boyd
4 Sep 19
4
Steven Boyd
29 Aug 19
4
Steven Boyd
9 Aug 19
4
Steven Boyd
26 Jul 19